Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Restructuring Costs came in at $9.0 million in Q2 2026, down 70.97% year-over-year from $31.0 million in Q2 2025, and down 30.77% quarter-over-quarter from $13.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Restructuring Costs across 18 years of filings, most recently posting $9.0 million for Q2 2026.

  • In Q2 2026, Restructuring Costs fell 70.97% year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at $67.0 million (up 67.5% YoY), while the FY2025 annual figure was $77.0 million, up 140.62% from the prior year.
  • Restructuring Costs came in at $9.0 million for Q2 2026 at Bausch Health Companies, down from $13.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $35.0 million in Q2 2022 to a low of $1.0 million in Q3 2024.
  • Average Restructuring Costs over 5 years is $14.2 million, with a median of $12.5 million recorded in 2022.
  • Year-over-year, Restructuring Costs slumped 92.86% in 2024 and surged 1600.0% in 2025.
  • Over 5 years, Restructuring Costs stood at $5.0 million in 2022, then jumped by 340.0% to $22.0 million in 2023, then plunged by 68.18% to $7.0 million in 2024, then surged by 300.0% to $28.0 million in 2025, then slumped by 67.86% to $9.0 million in 2026.
  • Per Business Quant data, the three most recent Restructuring Costs figures were $9.0 million in Q2 2026, $13.0 million in Q1 2026, and $28.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Mar 31, 2026 13.00 Mn
Dec 31, 2025 28.00 Mn
Sep 30, 2025 17.00 Mn
Jun 30, 2025 31.00 Mn
Mar 31, 2025 1.00 Mn
Dec 31, 2024 7.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 12.00 Mn
Mar 31, 2024 12.00 Mn
Dec 31, 2023 22.00 Mn
Sep 30, 2023 14.00 Mn
Jun 30, 2023 16.00 Mn
Mar 31, 2023 10.00 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2022 10.00 Mn
Jun 30, 2022 35.00 Mn
Mar 31, 2022 13.00 Mn
Dec 31, 2021 21.00 Mn
Sep 30, 2021 8.00 Mn